Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2014-08-01 Director's Dealing
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Director's Dealing 2014
Director's Dealing
2014-08-01 Danish
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 99% confidence The document details transactions related to a share buyback program ('aktietilbagekøbsprogram') conducted by Novozymes between February and August 2014, specifically reporting the activity up to July 31, 2014. It specifies the number of shares bought back, the transaction value, and the resulting number of own shares held. This activity directly relates to the company managing its own stock capital. The most fitting category among the provided definitions is 'Transaction in Own Shares' (POS), which covers share repurchase/issuance. It is not a general financing update (CAP) but a specific report on repurchases.
2014-08-01 English
Director's Dealing 2014
Director's Dealing
2014-07-25 Danish
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 99% confidence The document text, dated July 25, 2014, details transactions where Novozymes has bought back its own B-shares under a previously announced share repurchase program (aktietilbagekøbsprogram). It provides specific daily transaction volumes, average purchase prices, and the total number of own shares held after these transactions. This activity directly relates to the company managing its own stock capital. The most specific category for reporting the company buying back its own shares is 'Transaction in Own Shares' (POS). It is not a general financing update (CAP) or a change in capital structure announcement (SHA), but a report on the execution of a buyback program.
2014-07-25 English
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text is very short (396 characters) and explicitly states that Novozymes has bought back shares under a previously announced share repurchase program ('aktietilbagekøbsprogram'). It details the number of shares bought and the transaction value. The final sentence, 'Læs hele meddelelsen i pdf format' (Read the entire announcement in pdf format), strongly suggests this is a brief announcement about a transaction rather than the full regulatory filing detailing the transaction. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase reports. Although it is a short announcement, the specific nature of the content (share repurchase activity) overrides the general 'RPA' rule, as POS is a more specific category for this activity.
2014-07-18 Danish
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program' initiated on February 17, 2014, with a total value mentioned. This directly relates to the company acquiring its own shares. The filing category 'Transaction in Own Shares' (POS) is the most appropriate fit for reporting share repurchases. Although it mentions reading the full announcement in PDF format, the core content is the transaction report itself, not just an announcement of a report's availability, and it is more specific than the general 'RPA' or 'RNS' fallback.
2014-07-18 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.